Recent research suggests that high-deductible plans result in reduced spending over at least a three year time frame.
Read More
German medical services and products company Fresenius is buying NxStage Medical, which offers home dialysis equipment and services, for $2 billion.
https://www.nephrologynews.com/fresenius-medical-care-acquire-nxstage-medical/?utm_source=newsletter_080817&utm_medium=email&utm_campaign=newsletter&mkt_tok=eyJpIjoiWVRRelpEQTNOVFJoTW1FMyIsInQiOiI2RnpDb210bU04TnBwVWhOd2k2dlJGNmEyc3krZTZpaTZPZHZ1MHZ3Z3B4eVZpYUJQTVwvZ1Z6K2hnbzZ5b0ZZZWJPY01QNlJXN0JqQ2tYMFM3VGpUb0t0ZE8zZ1hZdlJZNDhNbWpJbFYzN2Zpb1laWEViWWR4MkowR2RhYjNyWEgifQ%3D%3DResearch in the Journal of Health Economics estimates the costs of developing a new medication.
Read More
A study in the Journal of Health Economics once again indicates that disease management programs have a hard time creating spending reductions that cover the cost of the program.
Read More
A survey from Manhattan Research examines drug company sales representatives interactions with physicians.
Read More
Lots of CRO deals lately. Now Evotec, a Germany-based vendor focusing on pre-clinical development, is acquiring Aptuit, which provides similar services, for $300 million.
http://www.fiercebiotech.com/cro/evotec-to-fill-pre-ind-service-gap-300m-aptuit-buy?mkt_tok=eyJpIjoiWm1ObFlUQm1NalUxT1RrNCIsInQiOiJ6UENNRjVhazRoS2Yycjg2XC9ydEtXRmJRVDZQRzJMNEJ2UGdqQlwvYTBvS1JDWnpzZHFQRTN0TEZueXBFUlcyWFZqWDBcL3VsSXhiSWpZNWdnRVwvbW1LVk8yVFN0Tm5lN29CekJMdm5tdkhOUFdNRWU1XC9FamN1bnVhS3BEbWc3K0NCIn0%3D&mrkid=635530&utm_medium=nl&utm_source=internalContract research firm Icon is buying Mapi, which provides data and analysis on the economic and other outcome benefits of drugs.
http://www.fiercebiotech.com/cro/icon-enhances-commercialization-arm-mapi-buy-reports-record-q2?mkt_tok=eyJpIjoiTldaaE5tUTBNREkxTURFMCIsInQiOiIrcHNGbUhXcUZTcjdGMmpwakxRRjdMZUU3QVVcL1RSRmlHcVo3Vm5UWjZyY2F2SDN3TXdXOTBpVmxsRVJNREl0TFFmQ1hhMHh5XC9lRzJEaFBiQ1NoTGw4Z3dJYjFBRmFXU0pCY2YzWlwvUFkxeFVRajdLRCtPRjRRbXcySlRUSzVHQyJ9&mrkid=635530&utm_medium=nl&utm_source=internalResearch carried by the Journal of the American Medical Association looks at the impact of social factors and medical risk on valued-based purchasing program performance.
Read More
In a study of medical home implementation at federally qualified health centers, researchers found that costs increased.
Read More